Pharmaceutical Patents and Prices : A Preliminary Empirical Assessment Using Data from India
The enforcement of stringent intellectual property rights in the pharmaceutical sector of developing countries generates considerable controversy, due to both the extensive research investment and the public policy importance of this sector. This paper explores the likely effects of enforcing produc...
| Main Authors: | , |
|---|---|
| Format: | Policy Research Working Paper |
| Language: | English |
| Published: |
World Bank, Washington, DC
2012
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/2012/05/16258614/pharmaceutical-patents-prices-preliminary-empirical-assessment-using-data-india-pharmaceutical-patents-prices-preliminary-empirical-assessment-using-data-india http://hdl.handle.net/10986/9342 |
| id |
okr-10986-9342 |
|---|---|
| recordtype |
oai_dc |
| spelling |
okr-10986-93422021-04-23T14:02:44Z Pharmaceutical Patents and Prices : A Preliminary Empirical Assessment Using Data from India Duggan, Mark Goyal, Aparajita ACCESS TO PHARMACEUTICALS ACTIVE INGREDIENTS ADVERTISING ANALGESICS ANTIBIOTICS AUDITS AVERAGE PRICE AVERAGE PRICES BRAND BRAND NAME BRANDS CAPSULES CHEMISTS COMBINATION DRUGS COPYRIGHTS DELIVERY SYSTEMS DOSAGE FORMS DRUG PRICES DRUGS GOVERNMENT POLICY HEALTH CARE HOSPITALS IMPORTED DRUGS INFORMATION ON PRODUCT INFRINGEMENT INNOVATIONS INTELLECTUAL PROPERTY INTELLECTUAL PROPERTY PROTECTION INTELLECTUAL PROPERTY RIGHTS INVENTION INVENTIONS JOINT VENTURES LAWS LEGAL PROTECTION LICENSE LICENSES LICENSING MANUFACTURING MARGINAL COSTS MARKET ENTRY MARKET POWER MARKET RESEARCH MARKET RESEARCH FIRM MARKET STRUCTURE MARKETING MARKETING STRATEGIES MATERIAL MEDICINE OPEN ACCESS PATENT PATENT ACT PATENT APPLICATION PATENT APPLICATIONS PATENT LAW PATENT LAWS PATENT LEGISLATION PATENT OFFICES PATENT POLICIES PATENT PROTECTION PATENT REFORM PATENT RIGHTS PATENT SYSTEMS PATENT TERM PATENTABILITY PATENTED PRODUCTS PERSONAL COMMUNICATION PHARMACEUTICAL PHARMACEUTICAL INDUSTRY PHARMACEUTICAL LAW PHARMACEUTICAL MANUFACTURERS PHARMACEUTICAL PATENTS PHARMACEUTICAL PRICES PHARMACEUTICAL PRICING PHARMACEUTICAL PRODUCTS PHARMACEUTICAL SECTOR PHARMACEUTICAL TREATMENTS PHARMACEUTICALS INDUSTRY PHARMACOECONOMICS PHARMACY PRICE CHANGE PRICE COMPETITION PRICE CONTROL PRICE CONTROLS PRICE INCREASE PRICE INCREASES PRICING POLICY PROCUREMENT PRODUCTION PROCESS PUBLIC HEALTH PURCHASING R&D RESEARCH INVESTMENT RESULT RESULTS RETAIL RETAIL SALES RETENTION SALES SEDATIVES SUBSTITUTES SUBSTITUTION SUPPLIER TABLETS TECHNICAL COOPERATION TECHNOLOGICAL INNOVATION TECHNOLOGY TRANSFERS TIME PERIOD TOTAL SALES TRADEMARKS USES VACCINES WEB WORLD TRADE The enforcement of stringent intellectual property rights in the pharmaceutical sector of developing countries generates considerable controversy, due to both the extensive research investment and the public policy importance of this sector. This paper explores the likely effects of enforcing product patents on prices and utilization of drugs in the Central Nervous System market in India. The Central Nervous System segment is the second largest therapeutic category in terms of retail sales in the world and is one of the fastest growing segments in India. Using information on product patents granted by the government and panel data on pharmaceutical prices and utilization from 2003-2008, the paper finds limited evidence of overall price increase following the introduction of product patents. However, there appear to be heterogeneous effects on prices by the type of product patent granted on drugs, implying the need for a careful examination of the product patent portfolio. 2012-06-29T21:18:53Z 2012-06-29T21:18:53Z 2012-05 http://documents.worldbank.org/curated/en/2012/05/16258614/pharmaceutical-patents-prices-preliminary-empirical-assessment-using-data-india-pharmaceutical-patents-prices-preliminary-empirical-assessment-using-data-india http://hdl.handle.net/10986/9342 English Policy Research Working Paper; No. 6063 CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo/ World Bank World Bank, Washington, DC Publications & Research :: Policy Research Working Paper Publications & Research South Asia India |
| repository_type |
Digital Repository |
| institution_category |
Foreign Institution |
| institution |
Digital Repositories |
| building |
World Bank Open Knowledge Repository |
| collection |
World Bank |
| language |
English |
| topic |
ACCESS TO PHARMACEUTICALS ACTIVE INGREDIENTS ADVERTISING ANALGESICS ANTIBIOTICS AUDITS AVERAGE PRICE AVERAGE PRICES BRAND BRAND NAME BRANDS CAPSULES CHEMISTS COMBINATION DRUGS COPYRIGHTS DELIVERY SYSTEMS DOSAGE FORMS DRUG PRICES DRUGS GOVERNMENT POLICY HEALTH CARE HOSPITALS IMPORTED DRUGS INFORMATION ON PRODUCT INFRINGEMENT INNOVATIONS INTELLECTUAL PROPERTY INTELLECTUAL PROPERTY PROTECTION INTELLECTUAL PROPERTY RIGHTS INVENTION INVENTIONS JOINT VENTURES LAWS LEGAL PROTECTION LICENSE LICENSES LICENSING MANUFACTURING MARGINAL COSTS MARKET ENTRY MARKET POWER MARKET RESEARCH MARKET RESEARCH FIRM MARKET STRUCTURE MARKETING MARKETING STRATEGIES MATERIAL MEDICINE OPEN ACCESS PATENT PATENT ACT PATENT APPLICATION PATENT APPLICATIONS PATENT LAW PATENT LAWS PATENT LEGISLATION PATENT OFFICES PATENT POLICIES PATENT PROTECTION PATENT REFORM PATENT RIGHTS PATENT SYSTEMS PATENT TERM PATENTABILITY PATENTED PRODUCTS PERSONAL COMMUNICATION PHARMACEUTICAL PHARMACEUTICAL INDUSTRY PHARMACEUTICAL LAW PHARMACEUTICAL MANUFACTURERS PHARMACEUTICAL PATENTS PHARMACEUTICAL PRICES PHARMACEUTICAL PRICING PHARMACEUTICAL PRODUCTS PHARMACEUTICAL SECTOR PHARMACEUTICAL TREATMENTS PHARMACEUTICALS INDUSTRY PHARMACOECONOMICS PHARMACY PRICE CHANGE PRICE COMPETITION PRICE CONTROL PRICE CONTROLS PRICE INCREASE PRICE INCREASES PRICING POLICY PROCUREMENT PRODUCTION PROCESS PUBLIC HEALTH PURCHASING R&D RESEARCH INVESTMENT RESULT RESULTS RETAIL RETAIL SALES RETENTION SALES SEDATIVES SUBSTITUTES SUBSTITUTION SUPPLIER TABLETS TECHNICAL COOPERATION TECHNOLOGICAL INNOVATION TECHNOLOGY TRANSFERS TIME PERIOD TOTAL SALES TRADEMARKS USES VACCINES WEB WORLD TRADE |
| spellingShingle |
ACCESS TO PHARMACEUTICALS ACTIVE INGREDIENTS ADVERTISING ANALGESICS ANTIBIOTICS AUDITS AVERAGE PRICE AVERAGE PRICES BRAND BRAND NAME BRANDS CAPSULES CHEMISTS COMBINATION DRUGS COPYRIGHTS DELIVERY SYSTEMS DOSAGE FORMS DRUG PRICES DRUGS GOVERNMENT POLICY HEALTH CARE HOSPITALS IMPORTED DRUGS INFORMATION ON PRODUCT INFRINGEMENT INNOVATIONS INTELLECTUAL PROPERTY INTELLECTUAL PROPERTY PROTECTION INTELLECTUAL PROPERTY RIGHTS INVENTION INVENTIONS JOINT VENTURES LAWS LEGAL PROTECTION LICENSE LICENSES LICENSING MANUFACTURING MARGINAL COSTS MARKET ENTRY MARKET POWER MARKET RESEARCH MARKET RESEARCH FIRM MARKET STRUCTURE MARKETING MARKETING STRATEGIES MATERIAL MEDICINE OPEN ACCESS PATENT PATENT ACT PATENT APPLICATION PATENT APPLICATIONS PATENT LAW PATENT LAWS PATENT LEGISLATION PATENT OFFICES PATENT POLICIES PATENT PROTECTION PATENT REFORM PATENT RIGHTS PATENT SYSTEMS PATENT TERM PATENTABILITY PATENTED PRODUCTS PERSONAL COMMUNICATION PHARMACEUTICAL PHARMACEUTICAL INDUSTRY PHARMACEUTICAL LAW PHARMACEUTICAL MANUFACTURERS PHARMACEUTICAL PATENTS PHARMACEUTICAL PRICES PHARMACEUTICAL PRICING PHARMACEUTICAL PRODUCTS PHARMACEUTICAL SECTOR PHARMACEUTICAL TREATMENTS PHARMACEUTICALS INDUSTRY PHARMACOECONOMICS PHARMACY PRICE CHANGE PRICE COMPETITION PRICE CONTROL PRICE CONTROLS PRICE INCREASE PRICE INCREASES PRICING POLICY PROCUREMENT PRODUCTION PROCESS PUBLIC HEALTH PURCHASING R&D RESEARCH INVESTMENT RESULT RESULTS RETAIL RETAIL SALES RETENTION SALES SEDATIVES SUBSTITUTES SUBSTITUTION SUPPLIER TABLETS TECHNICAL COOPERATION TECHNOLOGICAL INNOVATION TECHNOLOGY TRANSFERS TIME PERIOD TOTAL SALES TRADEMARKS USES VACCINES WEB WORLD TRADE Duggan, Mark Goyal, Aparajita Pharmaceutical Patents and Prices : A Preliminary Empirical Assessment Using Data from India |
| geographic_facet |
South Asia India |
| relation |
Policy Research Working Paper; No. 6063 |
| description |
The enforcement of stringent intellectual property rights in the pharmaceutical sector of developing countries generates considerable controversy, due to both the extensive research investment and the public policy importance of this sector. This paper explores the likely effects of enforcing product patents on prices and utilization of drugs in the Central Nervous System market in India. The Central Nervous System segment is the second largest therapeutic category in terms of retail sales in the world and is one of the fastest growing segments in India. Using information on product patents granted by the government and panel data on pharmaceutical prices and utilization from 2003-2008, the paper finds limited evidence of overall price increase following the introduction of product patents. However, there appear to be heterogeneous effects on prices by the type of product patent granted on drugs, implying the need for a careful examination of the product patent portfolio. |
| format |
Publications & Research :: Policy Research Working Paper |
| author |
Duggan, Mark Goyal, Aparajita |
| author_facet |
Duggan, Mark Goyal, Aparajita |
| author_sort |
Duggan, Mark |
| title |
Pharmaceutical Patents and Prices : A Preliminary Empirical Assessment Using Data from India |
| title_short |
Pharmaceutical Patents and Prices : A Preliminary Empirical Assessment Using Data from India |
| title_full |
Pharmaceutical Patents and Prices : A Preliminary Empirical Assessment Using Data from India |
| title_fullStr |
Pharmaceutical Patents and Prices : A Preliminary Empirical Assessment Using Data from India |
| title_full_unstemmed |
Pharmaceutical Patents and Prices : A Preliminary Empirical Assessment Using Data from India |
| title_sort |
pharmaceutical patents and prices : a preliminary empirical assessment using data from india |
| publisher |
World Bank, Washington, DC |
| publishDate |
2012 |
| url |
http://documents.worldbank.org/curated/en/2012/05/16258614/pharmaceutical-patents-prices-preliminary-empirical-assessment-using-data-india-pharmaceutical-patents-prices-preliminary-empirical-assessment-using-data-india http://hdl.handle.net/10986/9342 |
| _version_ |
1764409201985060864 |